News

Gladstone in the News August 2, 2020

“We’re Missing Huge Amounts of Data.” Why We Still Can’t Track the Spread of COVID-19 across the Bay Area

San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, comments on the lack of data impeding efforts to understand the spread of the coronavirus in California, and the necessity to wear masks.

Gladstone Experts COVID-19 Center for HIV Cure Research Greene Lab

Gladstone in the News July 31, 2020

Inside SF’s New Biosafety Lab, Where Scientists Wrangle Live Coronavirus

KQED—Mauricio Montano, director of Gladstone's new BSL-3 lab, and Melanie Ott, director of the Gladstone Institute of Virology, explain how scientists will use the high-level biosafety lab for COVID-19 research, and how they must gear up before getting in the door.

Gladstone Experts COVID-19 Infectious Disease Greene Lab Ott Lab

Article July 27, 2020

Finding Answers to COVID-19 in a High-Containment “BSL-3” Virus Lab

Scientists at Gladstone Institutes hope to unlock barriers to SARS-CoV-2 treatments and prevention in a lab certified to handle airborne pathogens

Facilities Office of the President Institutional News News Release COVID-19 Infectious Disease Ott Lab

Video July 24, 2020

My Diversity Story: Strengthening Innovation and Social Outcomes

UC Davis Chancellor Gary S. May spoke to the Gladstone community on increasing diversity in STEM.

Institutional News Diversity

Gladstone in the News July 23, 2020

Face Masks Really Do Matter. The Scientific Evidence Is Growing.

The Wall Street Journal—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, stresses wearing a mask as one of the most important things people can do right now to bring the spread of the coronavirus under control.

Gladstone Experts COVID-19 Infectious Disease Ott Lab

Gladstone in the News July 21, 2020

Inhaled Treatment Reduces Severe COVID-19 Risk by 79 Percent

Labiotech.eu—Senior Investigator Warner Greene, MD, PhD, comments on the use of interferons as therapeutic intervention in the early stages of COVID-19.

Gladstone Experts COVID-19 Center for HIV Cure Research Greene Lab

Article July 21, 2020

Crunching the Numbers to Determine Patient Outcomes

With a tool capable of taking large sets of data and distilling it into patterns, researchers at Gladstone hope to better predict COVID-19 patient outcomes and improve patient care.

Gladstone Experts COVID-19 Data Science and Biotechnology Infectious Disease Greene Lab Pollard Lab Roan Lab AI Big Data

Gladstone in the News July 20, 2020

Those Fleeting, Pesky Coronavirus Antibodies Are Going to Make Developing a Vaccine Awfully Difficult

KNX 1070—Senior Investigator Warner Greene, MD, PhD, comments on the recent findings that antibodies against SARS-CoV-2, the cause of COVID-19, disappear quickly from people's blood after they recover from infection, and discusses the implications for vaccine development.

Gladstone Experts COVID-19 Center for HIV Cure Research Greene Lab

Gladstone in the News July 20, 2020

Revealing the Genetic Signature of Neurodegenerative Disease

Drug Target Review—Senior Investigator Katerina Akassoglou, PhD, explains her team’s recent discovery of the immune cells in the brain that promote neurodegeneration in diseases such as multiple sclerosis and Alzheimer’s disease.

Gladstone Experts Multiple Sclerosis Alzheimer’s Disease Neurological Disease Akassoglou Lab

Gladstone in the News July 20, 2020

When Students Return to Class, How Can Parents Reduce Virus Risk?

NBC Bay Area—Senior Investigator Warner Greene, MD, PhD, gives advice on how to protect kids from COVID-19 and train them to practice good hygiene in preparation for back-to-school.

Gladstone Experts COVID-19 Center for HIV Cure Research Greene Lab

Gladstone in the News July 16, 2020

With Coronavirus Antibodies Fading Fast, Vaccine Hopes Fade Too

San Francisco Chronicle—Commenting on the disappointing recent reports about antibodies as barriers against coronavirus infection, Senior Investigator Nevan Krogan, PhD, and Visiting Scientist Danielle Swaney, PhD, emphasize the need for drug treatments as an alternative, and describe how they look for such treatments.

Gladstone Experts COVID-19 Data Science and Biotechnology Krogan Lab

Gladstone in the News July 16, 2020

What Are Antibodies?

Live Science—Senior Investigator Warner Greene, MD, PhD, lends his expertise in immunology to a detailed article describing the various types of antibodies the immune system produces during an infection, and how they help fight invaders or can be used as therapies.

Gladstone Experts COVID-19 Autoimmune Diseases Center for HIV Cure Research Greene Lab

Gladstone in the News July 15, 2020

Bay Area Counties Struggle with the Surging Coronavirus as Economies Shut Back Down

San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, blames the easing of restrictions in the spring on the recent uptick in COVID-19 confirmed cases, hospitalizations, and deaths in many California counties.

Gladstone Experts COVID-19 Center for HIV Cure Research Greene Lab

Gladstone in the News July 12, 2020

Why a Coronavirus Vaccine Won’t End the Pandemic by Itself

San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, explains that just like with HIV/AIDS, combination drug therapy might offer a reasonable option to protect against COVID-19 until good vaccines come along.

Gladstone Experts COVID-19 Center for HIV Cure Research Greene Lab

Video July 7, 2020

Gaslighting in the Academy: Actually Making Black Lives Matter

Learn how to transform academic culture

Institutional News Diversity